Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

ThermoGenesis Holdings to Participate in Investor Conferences in September


RANCHO CORDOVA, Calif., Aug. 31, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced management's participation in the following investor conferences in September.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpresstm platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact: 
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact: 
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

SOURCE ThermoGenesis Holdings, Inc.


These press releases may also interest you

at 09:15
Epic Sciences, Inc. and Predicine, Inc. today announced they have entered into a global strategic partnership to offer biopharmaceutical companies access to both Predicine's ctDNA-based testing and Epic's CTC-based testing. Predicine's lead offering...

at 09:14
Schweiger Dermatology Group (SDG) announced today that it has acquired the Harkaway Center for Dermatology and Aesthetics, with locations in Delran and Northfield, New Jersey. Dr. Karen Harkaway, who has an extensive background in cosmetic...

at 09:13
Stirling Ultracold, innovative developer and manufacturer of ultra-low temperature (ULT) freezers for life science and biopharma research, today announced it is the only company that offers commercially available freezers capable of storing any...

at 09:12
Today eHealth, Inc. (eHealth.com) released results from a new survey of more than 2,100 Medicare beneficiaries on the politics of Medicare and the coronavirus. Key findings from the survey: A majority of Medicare beneficiaries support early buy-in...

at 09:10
AbCellera and Kodiak Sciences Inc. , today announced a new partnership to generate therapeutic antibody candidates in ophthalmology. Following a previously successful collaboration, AbCellera will use its full stack, AI-powered antibody discovery...

at 09:10
hc1, the leader in critical insight, analytics, and solutions for precision health that power high-value health care, announced today that Stephen K. Klasko, MD, MBA, will be the keynote speaker during its Precision Health Virtual Summit scheduled...



News published on 31 august 2020 at 08:30 and distributed by: